ProfileGDS2244 / 201932_at
TitleMelanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OrganismHomo sapiens


E2F-1 doxorubicin E2F-1 and doxorubicin GSM52504 GSM52508 GSM52518 GSM52519 GSM52516 GSM52517 71% 69% 74% 76% 70% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM52504SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1)121.971
GSM52508SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2)111.869
GSM52518SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1)143.674
GSM52519SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2)162.376
GSM52516SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1)116.870
GSM52517SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2)94.367